Table of Contents
Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Report 2018
1 Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Therapeutics and Diagnostics
1.2 Classification of Alzheimer’s Disease Therapeutics and Diagnostics by Product Category
1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Biomarkers
1.2.4 Cholinesterase inhibitors
1.2.5 NMDA receptor antagonists
1.2.6 Brain imaging
1.2.7 Blood tests
1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Application/End Users
1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Drugs Market
1.3.2 Diagnostics Market
1.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Region
1.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.4 China Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.5 Japan Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.7 India Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Alzheimer’s Disease Therapeutics and Diagnostics (2013-2025)
1.5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2025)
1.5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2025)
2 Global Alzheimer’s Disease Therapeutics and Diagnostics Competition by Players/Suppliers, Type and Application
2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Competition by Players/Suppliers
2.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume and Value) by Type
2.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
2.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
2.3 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume and Value) by Region
2.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Region (2013-2018)
2.3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Region (2013-2018)
2.4 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume) by Application
3 United States Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
3.1 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
3.1.1 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
3.1.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
3.1.3 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
3.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)
4 Europe Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
4.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
4.1.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.1.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
4.1.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
4.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)
5 China Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
5.1 China Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
5.1.1 China Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5.1.2 China Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
5.1.3 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
5.2 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
5.3 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
5.4 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)
6 Japan Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
6.1 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
6.1.1 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.1.2 Japan Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6.1.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
6.2 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
7.1 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
7.1.1 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
7.2 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)
8 India Alzheimer’s Disease Therapeutics and Diagnostics (Volume, Value and Sales Price)
8.1 India Alzheimer’s Disease Therapeutics and Diagnostics Sales and Value (2013-2018)
8.1.1 India Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8.1.2 India Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
8.1.3 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Price Trend (2013-2018)
8.2 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
8.3 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
8.4 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)
9 Global Alzheimer’s Disease Therapeutics and Diagnostics Players/Suppliers Profiles and Sales Data
9.1 Namenda
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Namenda Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Aricept
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Aricept Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Exelon
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Exelon Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Solanezumab
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Solanezumab Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Gantenerumab
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Gantenerumab Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Verubecestat
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Verubecestat Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Pfizer
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Eisai
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Actavis
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Actavis Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Lundbeck
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Daiichi Sankyo
9.12 Novartis
9.13 TauRx
10 Alzheimer’s Disease Therapeutics and Diagnostics Maufacturing Cost Analysis
10.1 Alzheimer’s Disease Therapeutics and Diagnostics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Alzheimer’s Disease Therapeutics and Diagnostics
10.3 Manufacturing Process Analysis of Alzheimer’s Disease Therapeutics and Diagnostics
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Alzheimer’s Disease Therapeutics and Diagnostics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Alzheimer’s Disease Therapeutics and Diagnostics Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Forecast (2018-2025)
14.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Price and Trend Forecast (2018-2025)
14.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Forecast by Type (2018-2025)
14.3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Forecast by Type (2018-2025)
14.3.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Price Forecast by Type (2018-2025)
14.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Figure Product Picture of Alzheimer's Disease Therapeutics and Diagnostics
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (Product Category) in 2017
Figure Biomarkers Product Picture
Figure Cholinesterase inhibitors Product Picture
Figure NMDA receptor antagonists Product Picture
Figure Brain imaging Product Picture
Figure Blood tests Product Picture
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Application in 2017
Figure Drugs Market Examples
Table Key Downstream Customer in Drugs Market
Figure Diagnostics Market Examples
Table Key Downstream Customer in Diagnostics Market
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (Million USD) by Regions (2013-2025)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers
Figure 2017 Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Players/Suppliers
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players
Table 2017 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Players
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Market Share by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Type (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Type (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Growth Rate by Type (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share by Region (2013-2018)
Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate by Region in 2017
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Growth Rate by Region in 2017
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Region in 2017
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Alzheimer's Disease Therapeutics and Diagnostics by Application (2013-2018)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Application (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Table Namenda Basic Information List
Table Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Namenda Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Aricept Basic Information List
Table Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Aricept Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Exelon Basic Information List
Table Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Exelon Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Solanezumab Basic Information List
Table Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Gantenerumab Basic Information List
Table Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Verubecestat Basic Information List
Table Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Pfizer Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Eisai Basic Information List
Table Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Eisai Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Actavis Basic Information List
Table Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Actavis Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Lundbeck Basic Information List
Table Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Daiichi Sankyo Basic Information List
Table Novartis Basic Information List
Table TauRx Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer's Disease Therapeutics and Diagnostics
Figure Manufacturing Process Analysis of Alzheimer's Disease Therapeutics and Diagnostics
Figure Alzheimer's Disease Therapeutics and Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer's Disease Therapeutics and Diagnostics Major Players in 2017
Table Major Buyers of Alzheimer's Disease Therapeutics and Diagnostics
Table Distributors/Traders List
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share Forecast by Regions in 2025
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share Forecast by Regions in 2025
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2018-2025)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) Forecast by Type (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share Forecast by Type (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) Forecast by Application (2018-2025)
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
【レポートのキーワード】
アルツハイマー病治療薬・診断薬、バイオマーカー、コリンエステラーゼ阻害剤、NMDA受容体アンタゴニスト、脳イメージング、血液検査、薬市場、診断薬市場